2-chloro-n(6)cyclopentyladenosine has been researched along with pyrazolopyridine in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (pyrazolopyridine) | Trials (pyrazolopyridine) | Recent Studies (post-2010) (pyrazolopyridine) |
---|---|---|---|---|---|
252 | 0 | 43 | 104 | 0 | 59 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akahane, A; Butcher, SP; Finlayson, K; Ito, H; Maemoto, T; Olverman, HJ | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and pyrazolopyridine
Article | Year |
---|---|
Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.
Topics: Adenosine; Animals; Binding, Competitive; Cerebral Cortex; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Protein Binding; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1 | 1999 |